These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
185 value dossier vacancies are available with Pro Membership → Prova 5 giorni gratis
Bologna, Italy. This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence-generation, and health policy strategies for Alfasigma’s specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working … Leggi di più
Raleigh, NC, US. We are seeking a highly motivated and detail-oriented intern to join our Medical & Scientific Affairs and Market Access team. This internship offers a unique opportunity to gain hands-on experience in the strategic and operational aspects of market access within a leading life sciences company. The intern will support initiatives that ensure optimal patient access to innovative … Leggi di più
Remote, US. At iRhythm, you’ll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what’s possible. We think big and move fast, driven by our commitment … Leggi di più
Hyderabad, India. The Global HEOR Value Writing Senior Associate plays a critical role in supporting Amgen’s global market access strategy through high-quality Health Technology Assessment (HTA) deliverables. This role collaborates closely with team lead and Global HEOR Product Leads to ensure alignment with product strategy. The Value Writing Senior Associate develops Global Value Dossiers (GVDs), US AMCP dossiers, EU JCA … Leggi di più
Cambridge, MA, US. The Director, US Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) is responsible for identifying real-world and economic evidence needs and developing the real-world, clinical, humanistic, and economic evidence generation plans in collaboration with internal business partners to support the value of our products for US healthcare providers, population-health decision makers, and other external … Leggi di più
OTTENERE L'ACCESSO A 100% CON PRo
L'accesso gratuito finisce qui
Vedi solo 30% di ruoli, con un ritardo di 7 giorni. Con la versione Pro, ne ottieni 100% immediatamente. 367 apri ruoli per i Membri Pro oggi.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
185 value dossier vacancies are available with Pro Membership → Prova 5 giorni gratis
Teniamo alla vostra privacy. Utilizziamo i cookie per migliorare la vostra esperienza sul nostro sito web, personalizzare i contenuti e gli annunci e analizzare il nostro traffico. Potete scegliere quali cookie autorizzare e potete revocare il vostro consenso in qualsiasi momento. Per ulteriori informazioni, consultare il nostro sito Informativa sui cookie.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
